Publications by authors named "Angela Alama"

Claim this Profile
E
Extracellular vesicles miR-574-5p and miR-181a-5p as prognostic markers in NSCLC patients treated with nivolumab.
Carlo Genova, Silvia Marconi, Giovanna Chiorino, Francesca Guana, Paola Ostano, Angela Alama

Clin Exp Med· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic Role of Soluble and Extracellular Vesicle-Associated PD-L1, B7-H3 and B7-H4 in Non-Small Cell Lung Cancer Patients Treated with Immune Checkpoint Inhibitors.
Carlo Genova, Roberta Tasso, Alessandra Rosa, Giovanni Rossi, Daniele Reverberi, Angela Alama

Cells· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunotherapy-chemotherapy combinations for non-small cell lung cancer: current trends and future perspectives.
Eugenia Cella, Lodovica Zullo, Silvia Marconi, Giovanni Rossi, Simona Coco, Angela Alama

Expert Opin Biol Ther· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune Checkpoint Blockade: A Strategy to Unleash the Potential of Natural Killer Cells in the Anti-Cancer Therapy.
Melania Grottoli, Paolo Carrega, Lodovica Zullo, Chiara Dellepiane, Giovanni Rossi, Angela Alama

Cancers (Basel)· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Circulating Risk Score, Based on Combined Expression of Exo-miR-130a-3p and Fibrinopeptide A, as Predictive Biomarker of Relapse in Resectable Non-Small Cell Lung Cancer Patients.
Silvia Marconi, Michela Croce, Giovanna Chiorino, Giovanni Rossi, Francesca Guana, Angela Alama

Cancers (Basel)· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serum levels of VCAM-1 are associated with survival in patients treated with nivolumab for NSCLC.
Federico Carbone, Stefano Ministrini, Aldo Bonaventura, Alessandra Vecchié, Silvia Minetti, Angela Alama

Eur J Clin Invest· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radiation-Related Deregulation of TUBB3 and BRCA1/2 and Risk of Secondary Lung Cancer in Women With Breast Cancer.
Simona Coco, Simona Boccardo, Marco Mora, Vincenzo Fontana, Irene Vanni, Angela Alama

Clin Breast Cancer· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and efficacy of immune checkpoint inhibitors in non-small-cell lung cancer: focus on challenging populations.
Lodovica Zullo, Giovanni Rossi, Chiara Dellepiane, Marco Tagliamento, Angela Alama

Immunotherapy· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association Between Response to Nivolumab Treatment and Peripheral Blood Lymphocyte Subsets in Patients With Non-small Cell Lung Cancer.
Selene Ottonello, Carlo Genova, Irene Cossu, Vincenzo Fontana, Erika Rijavec, Angela Alama

Front Immunol· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel Emerging Molecular Targets in Non-Small Cell Lung Cancer.
Sara Elena Rebuzzi, Lodovica Zullo, Giovanni Rossi, Massimiliano Grassi, Veronica Murianni, Angela Alama

Int J Mol Sci· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radiomic Detection of EGFR Mutations in NSCLC.
Giovanni Rossi, Emanuele Barabino, Alessandro Fedeli, Gianluca Ficarra, Simona Coco, Angela Alama

Cancer Res· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ADP ribose polymerase inhibitors for treating non-small cell lung cancer: new additions to the pharmacotherapeutic armamentarium.
Giovanni Rossi, Lodovica Zullo, Luigi Cerbone, Simona Coco, Luca Longo, Angela Alama

Expert Opin Pharmacother· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Baseline serum levels of osteopontin predict clinical response to treatment with nivolumab in patients with non-small cell lung cancer.
Federico Carbone, Francesco Grossi, Aldo Bonaventura, Alessandra Vecchié, Silvia Minetti, Angela Alama

Clin Exp Metastasis· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correlation between B7-H4 and Survival of Non-Small-Cell Lung Cancer Patients Treated with Nivolumab.
Carlo Genova, Simona Boccardo, Marco Mora, Erika Rijavec, Federica Biello, Angela Alama

J Clin Med· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serum PCSK9 levels at the second nivolumab cycle predict overall survival in elderly patients with NSCLC: a pilot study.
Aldo Bonaventura, Francesco Grossi, Federico Carbone, Alessandra Vecchié, Silvia Minetti, Angela Alama

Cancer Immunol Immunother· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic Relevance of Circulating Tumor Cells and Circulating Cell-Free DNA Association in Metastatic Non-Small Cell Lung Cancer Treated with Nivolumab.
Angela Alama, Simona Coco, Carlo Genova, Giovanni Rossi, Vincenzo Fontana

J Clin Med· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Microtubule-targeting agents in the treatment of non-small cell lung cancer: insights on new combination strategies and investigational compounds.
Marco Tagliamento, Carlo Genova, Giovanni Rossi, Simona Coco, Erika Rijavec, Angela Alama

Expert Opin Investig Drugs· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrated Somatic and Germline Whole-Exome Sequencing Analysis in Women with Lung Cancer after a Previous Breast Cancer.
Simona Coco, Silvia Bonfiglio, Davide Cittaro, Irene Vanni, Marco Mora, Angela Alama

Cancers (Basel)· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The evolving role of pemetrexed disodium for the treatment of non-small cell lung cancer.
Giovanni Rossi, Angela Alama, Carlo Genova, Erika Rijavec, Marco Tagliamento

Expert Opin Pharmacother· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Afatinib and Erlotinib in the treatment of squamous-cell lung cancer.
Marco Tagliamento, Carlo Genova, Erika Rijavec, Giovanni Rossi, Federica Biello, Angela Alama

Expert Opin Pharmacother· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circulating Tumor DNA Reflects Tumor Metabolism Rather Than Tumor Burden in Chemotherapy-Naive Patients with Advanced Non-Small Cell Lung Cancer: F-FDG PET/CT Study.
Silvia Morbelli, Angela Alama, Giulia Ferrarazzo, Simona Coco, Carlo Genova

J Nucl Med· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Downregulation of miR-99a/let-7c/miR-125b miRNA cluster predicts clinical outcome in patients with unresected malignant pleural mesothelioma.
Anna Truini, Simona Coco, Ernest Nadal, Carlo Genova, Marco Mora, Angela Alama

Oncotarget· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Understanding the checkpoint blockade in lung cancer immunotherapy.
Maria Giovanna Dal Bello, Angela Alama, Simona Coco, Irene Vanni, Francesco Grossi

Drug Discov Today· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply to the Letter to the Editor by C. Nicolazzo et al.: "Circulating Cell-Free DNA and Circulating Tumor Cells as Prognostic and Predictive Biomarkers in Advanced Non-Small Cell Lung Cancer Patients Treated with First-Line Chemotherapy".
Angela Alama, Simona Coco, Irene Vanni, Francesco Grossi

Int J Mol Sci· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circulating Cell-Free DNA and Circulating Tumor Cells as Prognostic and Predictive Biomarkers in Advanced Non-Small Cell Lung Cancer Patients Treated with First-Line Chemotherapy.
Simona Coco, Angela Alama, Irene Vanni, Vincenzo Fontana, Carlo Genova

Int J Mol Sci· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis